Elevance HealthELVEarnings & Financial Report
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon.
Revenue
$43.7B
Gross Profit
$39.3B
Operating Profit
$2.6B
Net Profit
$1.9B
Gross Margin
90.1%
Operating Margin
6.0%
Net Margin
4.2%
YoY Growth
13.0%
EPS
$7.79
Financial Flow
Elevance Health Q2 2023 Financial Summary
Elevance Health reported revenue of $43.7B for Q2 2023, with a net profit of $1.9B (4.2% margin). Cost of goods sold was $4.3B, operating expenses totaled $36.7B.
Key Financial Metrics
| Total Revenue | $43.7B |
|---|---|
| Net Profit | $1.9B |
| Gross Margin | 90.1% |
| Operating Margin | 6.0% |
| Report Period | Q2 2023 |
Elevance Health Annual Revenue by Year
Elevance Health annual revenue history includes year-by-year totals (for example, 2025 revenue was $199.1B).
| Year | Annual Revenue |
|---|---|
| 2025 | $199.1B |
| 2024 | $177.0B |
| 2023 | $171.3B |
| 2022 | $156.6B |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $43.89B | $45.11B | $45.44B | $48.89B | $49.78B | $50.71B | $49.75B | $49.75B |
| YoY Growth | 0.5% | 5.3% | 6.6% | 14.8% | 13.4% | 12.4% | 9.5% | 1.8% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $112.99B | $116.53B | $116.89B | $119.72B | $121.94B | $122.75B | $121.49B | $121.49B |
| Liabilities | $70.69B | $72.65B | $75.46B | $77.10B | $78.09B | $78.67B | $77.47B | $77.47B |
| Equity | $42.19B | $43.77B | $41.31B | $42.50B | $43.72B | $43.95B | $43.88B | $43.88B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $447.0M | $2.68B | $706.0M | $1.02B | $2.05B | $1.14B | $84.0M |
Other Health Care Companies
CNC
Centene Corporation
Revenue
$44.7B
Net Profit
$-1.1B
HUM
Humana
Revenue
$32.5B
Net Profit
$-796.0M
MOH
Molina Healthcare
Revenue
$11.4B
Net Profit
$-160.0M
UNH
UnitedHealth Group
Revenue
$113.2B
Net Profit
$2.3B
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
ABBV
AbbVie
Revenue
$15.8B
Net Profit
$186.0M
A
Agilent Technologies
Revenue
$1.9B
Net Profit
$434.0M
ALGN
Align Technology
Revenue
$995.7M
Net Profit
$56.8M
AMGN
Amgen
Revenue
$9.9B
Net Profit
$1.3B
BAX
Baxter International
Revenue
$3.0B
Net Profit
$-1.1B